Test Code TBGI Thyroxine-Binding Globulin (TBG), Serum
Reporting Name
Thyroxine Binding Globulin, SUseful For
Cases in which total thyroid hormone levels do not correlate with the thyrometabolic status, most commonly with pregnancy or the use of contraceptive steroids
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
SerumSpecimen Required
Patient Preparation: For 12 hours before specimen collection, do not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins.
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
0.35 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 30 days |
Day(s) Performed
Monday, Wednesday, Friday
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
84442
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
TBGI | Thyroxine Binding Globulin, S | 3021-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
TBGI | Thyroxine Binding Globulin, S | 3021-3 |
Clinical Information
Thyroxine binding globulin (TBG) is the high-affinity serum binding protein for thyroxine and triiodothyronine. Normally, the thyroid adjusts to changing concentrations of TBG by producing more, or less, thyroid hormone to maintain a constant level of metabolically important free hormone.
Elevated TBG levels are associated with influences such as pregnancy, genetic predisposition, oral contraceptives, and estrogen therapy. TBG levels can decrease with androgenic or anabolic steroids, large doses of glucocorticoids, hypoproteinemic states, liver disease, nephrotic syndrome, and congenital TBG variants.
Cautions
Females using estrogen-based contraception may exceed the reference range.
Report Available
1 to 3 daysSpecimen Retention Time
2 weeksReject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Method Name
Solid-Phase Chemiluminescent Assay